
A physician-guided review of long-term TRT safety, including cardiovascular and prostate evidence, fertility, hematocrit, blood pressure, side effects and monitoring.

A physician-reviewed 2026 update on the end of the tirzepatide shortage, FDA compounding rules, 503A and 503B restrictions, individualized prescriptions and what patients should know now.

A physician-reviewed guide to long-term GLP-1 treatment, including weight regain after stopping semaglutide or tirzepatide, maintenance therapy, lifestyle support and when discontinuation may be reasonable.

What testosterone studies show about lean mass and body fat, how TRT differs from performance enhancement, and why diagnosis, training and nutrition matter.

A physician-reviewed overview of GLP-1 medication benefits and risks, including semaglutide, tirzepatide, common side effects, serious warnings, muscle preservation and who may or may not be a good candidate.

Tesamorelin and HGH affect the growth hormone–IGF-1 axis differently. Compare mechanisms, approved uses, evidence, safety, and monitoring in this physician-reviewed guide.

A physician-reviewed comparison of enclomiphene and clomiphene (Clomid) for men with secondary hypogonadism, including testosterone, fertility, safety and treatment limitations.

Review what prostate studies can and cannot tell us about TRT and cancer, including screening limitations and individual cancer history.

Three different questions: category eligibility, anti-doping compliance and medical hormone testing. A practical guide to the 2026 rules and official sources.
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed